Integrative analysis reveals methylenetetrahydrofolate dehydrogenase 1-like as an independent shared diagnostic and prognostic biomarker in five different human cancers.

Nuzhat SialJalil Ur RehmanSaba SaeedMukhtiar AhmadYasir HameedMuhammad AtifAbdul RehmanRizwan AsifHamad AhmedMuhammad Safdar HussainMuhammad Rashid KhanAtifa AmbreenAyesha Ambreen

Published in: Bioscience reports (2022)

In conclusion, our results elucidated that MTHFD1L can serve as a shared diagnostic and prognostic biomarker in BLCA, HNSC, KIRP, LUAD, and UCEC patients of different clinicopathological features.

Keyphrases

end stage renal disease
endothelial cells
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
network analysis